|
|
||||||||
Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada N1G 2W1
| |
ABSTRACT |
|---|
|
|
|---|
Glutamate is central to several transamination reactions that affect the production of ammonia, alanine, glutamine, as well as TCA cycle intermediates during exercise. To further study glutamate metabolism, we administered 150 mg/kg body wt of monosodium glutamate (MSG) and placebo to seven male subjects who then either rested or exercised (15-min cycling at ~85% maximal oxygen consumption). MSG ingestion resulted in elevated plasma glutamate, aspartate, and taurine, both at rest and during exercise (P < 0.05), whereas most other amino acids were unchanged. Neither plasma alanine nor ammonia was altered at rest. During exercise and after glutamate ingestion, alanine was increased (P < 0.05) and ammonia was attenuated (P < 0.05). Glutamine was also elevated after glutamate ingestion during rest and exercise trials. MSG administration also resulted in elevated insulin levels (P < 0.05), which were parallel to the trend in C-peptide levels. Thus MSG can successfully elevate plasma glutamate, both at rest and during exercise. The plasma amino acid responses suggest that increased glutamate availability during exercise alters its distribution in transamination reactions within active muscle, which results in elevated alanine and decreased ammonia levels.
amino acids; insulin; alanine; taurine; monosodium glutamate; anaplerosis; ammonia; alanine aminotransferase
| |
INTRODUCTION |
|---|
|
|
|---|
GLUTAMATE IS A UNIQUE AMINO acid that is central to many metabolic processes in skeletal muscle. Not only does glutamate participate in the transamination of the branched-chain amino acids, but it is also pivotal to the formation of ammonia, aspartate, alanine, and glutamine (14, 17, 24, 32). Although glutamate is abundant in the skeletal muscle free amino acid pool, it is the primary amino acid taken up by resting and active muscle (10, 14, 17). At the onset of exercise, intramuscular glutamate decreases by ~40-80% and remains low during exercise, despite its constant uptake from circulation (7, 10, 16). During exercise, there is an elevated release of ammonia, glutamine, and alanine from the working muscle, suggesting that glutamate plays an important role in the transfer of amino groups and in the TCA cycle in skeletal muscle (7, 10, 12, 16).
Whereas glutamate is central to numerous reactions, it has rarely been manipulated. Plasma glutamate levels can be elevated by administering large doses of monosodium glutamate (MSG). However, most studies that have used this manipulation have focused on gut and liver metabolism and did not study muscle metabolism. After ingestion of ~100-150 mg/kg body wt of MSG, plasma glutamate levels can be elevated up to 700-800% (4, 9, 15, 25-29). Graham et al. (15) demonstrated that ingesting similar doses of MSG can elevate intramuscular glutamate concentrations at rest by ~40%. In resting subjects, Thomassen et al. (31) infused MSG and observed an elevated influx of glutamate into the leg, as well as a small but significant increase in femoral venous alanine. Both of these studies indicate that an increased availability of circulating glutamate can result in increased intramuscular glutamate at rest. A rise in insulin shortly after MSG administration was also a common observation to both studies (15, 31), implying that glutamate may stimulate insulin secretion at rest, as suggested in previous work (19, 23). Aoki et al. (1) have suggested that this rise in insulin may enhance the uptake of glutamate into muscle in humans. However, it is not known whether glutamate would also moderate the decline in insulin that is normally seen during exercise.
During exercise, when the extraction of glutamate from circulation is increased, it is not known whether elevated circulating glutamate levels from MSG ingestion can be maintained. Thomassen and coworkers (30) administered MSG orally and intravenously to coronary patients, who then exercised at a low intensity for variable periods of time. They showed that glutamate levels remained elevated for the duration of the short-exercise bout and plasma alanine was elevated with oral ingestion; however, these were the only amino acids measured in this study, and ammonia measurements were not included. Because glutamate is central to numerous reactions in amino acid metabolism, elevated glutamate levels could potentially affect ammonia, glutamine, and alanine production; provide more aspartate for the purine nucleotide cycle; and affect anaplerosis of the TCA cycle. As such, increasing circulating glutamate levels via MSG ingestion could ultimately serve as a tool to investigate the role of glutamate in muscle metabolism during exercise.
To further understand glutamate's role in rest and exercise metabolism, normal glutamate metabolism was manipulated by enhancing glutamate availability via MSG ingestion. Because glutamate availability may be functionally important to the TCA cycle flux, the decline in intramuscular glutamate at the onset of exercise needs to be understood. By providing glutamate in excess, glutamate availability in circulation is increased, which, subsequently, may be utilized by the skeletal muscle. In this study, MSG was administered to explore glutamate's effects on whole body metabolism and, indirectly, on muscle metabolism near the onset of exercise. The study was designed to 1) examine whether MSG can successfully elevate plasma glutamate levels and maintain these levels during exercise, 2) examine the shifts in plasma amino acids resulting from glutamate transamination after MSG ingestion during exercise, and 3) further examine the changes that MSG ingestion exerts on insulin at rest and during exercise. As such, we hypothesize that the ingestion of glutamate will result in an increase of circulating glutamate levels at rest and during exercise. This increase in circulating glutamate availability should also lead to an increase in plasma alanine, glutamine, and ammonia because these compounds intimately interact with intramuscular glutamate. Potential shifts in plasma amino acids will indirectly suggest specific alterations in muscle metabolism as a result of enhanced glutamate availability and direct future investigation.
| |
METHODS |
|---|
|
|
|---|
Seven healthy men with a mean age, body mass, and maximal oxygen
consumption (
O2 max) of 26.7 ± 2.0 yr, 75.8 ± 3.5 kg, and 56.8 ± 2.3 ml · kg
1 · min
1,
respectively, volunteered to participate in the study. All subjects were recreationally active to moderately trained individuals. Subjects
were informed verbally and in writing of the purpose and risks involved
with the experimental protocol, which was approved by the Human Ethics
Committee of the University of Guelph.
Experimental protocol. Subjects underwent four different trials: 1) exercise + MSG, 2) exercise + placebo (Plb), 3) rest + MSG, and 4) rest + Plb. The trials were conducted in a double-blind crossover manner and were each separated by at least 1 wk. For each trial, subjects arrived after an overnight fast. Subjects were asked to refrain from caffeine, aspartame, alcohol, and exercise for 2 days before each trial, and they used a checklist food record to maintain a consistent diet. They recorded their diets for 2 days before their first trial and referred to these records to maintain the same diet 2 days before each subsequent trial.
At the beginning of each trial, resting blood samples were taken, and pulmonary oxygen consumption (
O2) was
measured. Subjects were then provided with either Plb or MSG
(Ajinomoto) in gelatin capsule form. The dose of MSG, 150 mg/kg body
wt, was the same as that of previous studies (2, 15, 26-28,
30). During the rest trials, subjects were either sitting or
lying for the entire duration. Blood samples were taken in 10-min
intervals until 1 h postingestion, followed by 15-min intervals
until 2 h postingestion. Pulmonary measurements were made every 30 min (Applied Electrochemical S-3A O2 analyzer and
Sensormedics LB-2 CO2 analyzer).
During the exercise trials, subjects were provided with the MSG or Plb
capsules and then rested for 40 min. During this time, blood samples
were collected every 10 min. Previous work (9, 15,
25-28) has shown that peak plasma glutamate levels are
reached between 40 and 60 min after the ingestion of this dose of MSG. Therefore, at 40 min postingestion, subjects began exercising on the
cycle ergometer (Quinton Excalibur) at ~85%
O2 max for 15 min. At 15 min of
exercise, subjects stopped peddling and rested for 10 min (refer to
Fig. 1). Workloads for the exercise component of the trials were predetermined by using the subjects'
O2 max data. Blood was sampled 5, 10, and 15 min after exercise had commenced, as well as 10 min into
recovery. To avoid confusion when discussing results, the term
"rest" will be used in reference to the rest trial and the term
"preexercise" will be used for the resting portion of the exercise
trial.
|
Analyses.
For the analysis of amino acids, ammonia, sodium, chloride, and
potassium, blood was collected in tubes containing heparin. These were
centrifuged, and the plasma was stored at
80°C. Amino acids were
measured by using high-performance liquid chromatography, as previously
described (18). The electrolytes were measured by using
the NovaStat Profile 9+ (Nova Biomedical, Waltham, MA). For lactate and
glucose analysis, 200 µl of whole blood were deproteinized by using 1 ml of 0.6 M perchloric acid and stored at
80°C. A portion of the
blood sample was centrifuged, and the serum was stored at
80°C for
the analysis of insulin (Coat-A-Count, DPC, Los Angeles, CA), C peptide
(Human C-Peptide RIA Kit, Linco Research), free fatty acids (WAKO
Chemical USA), and glycerol. Ammonia, glucose, lactate, and glycerol
were analyzed by using fluorometric methods (5).
Statistics.
Peak values for each amino acid were determined by averaging the peak
values of a given amino acid from all subjects. Total amino acids were
calculated as the sum of all amino acids measured. The sum of
threonine, valine, methionine, isoleucine, leucine, phenylalanine, and
lysine was referred to as total essential amino acids. Tryptophan was
not included because it could not be measured precisely. Branched-chain
amino acids were calculated as the sum of valine, leucine, and
isoleucine. All data were analyzed by using a two-way repeated-measures
ANOVA (trial × condition). Statistical significance was accepted
at P
0.05, and analysis was conducted by using
Tukey's post hoc test. All data are expressed as means ±SE. During
exercise, the 45-, 55-, and 65-min time points (refer to Fig. 1) do not
have time points that correspond to the rest trials. Thus statistical
differences between exercise and rest within the same treatment at
these particular time points were analyzed in a slightly different
manner. The average between 40 and 50 min of the rest trial was
compared with 45 min of the exercise trial. Similarly, the average
between 50 and 60 min of the rest trial was compared with 55 min of the
exercise trial, whereas the time-weighted average between 60 and 75 min
was compared with 65 min of the exercise trial. To confirm our
statistical results, these exercise time points (45, 55, and 65 min)
were also compared with the original, resting trial time points that
occur before and after the given exercise time point (i.e., 45 min of
the exercise trial was compared with 40 and 50 min of the rest trial).
| |
RESULTS |
|---|
|
|
|---|
Respiratory and electrolyte data.
There were no changes in pulmonary measurements at rest; however, MSG
ingestion resulted in a mean
O2 increase
of ~2.5 ml · kg
1 · min
1
[49.6 ± 2.7 ml · kg
1 · min
1 (MSG) vs.
47.1 ± 1.7 ml · kg
1 · min
1 (Plb);
P < 0.05] during exercise. It is likely that this
increase in
O2 is a result of elevated
O2 in the exercising muscle, because
this increase was not seen during the rest trials. The mean relative
O2 workload at 10 and 15 min of exercise
was ~84.2 ± 2.3%
O2 max during
Plb, whereas the relative workload after MSG ingestion was ~87.9 ± 2.4%
O2 max. There were no
differences observed in respiratory exchange ratio. Changes in sodium,
chloride, and potassium did not result with MSG ingestion (data not presented).
Plasma amino acids.
MSG ingestion resulted in at least an 18-fold increase in plasma
glutamate (Fig. 2). During the rest
trial, the mean peak concentration was 470 ± 52 µM and occurred
from 40 to 60 min postingestion. However, during the exercise
trial, the increase in plasma glutamate after MSG ingestion was similar
but larger than that during the resting trial (P < 0.05), with a mean peak concentration of 630 ± 63 µM
(P < 0.001). This larger increase that was observed in the exercise trial coincided with the onset of exercise.
|
|
|
|
Ammonia.
Because ammonia levels are low and variable at rest, the ammonia data
were normalized to the Plb resting baseline values (Fig. 4). Plasma ammonia did not change
throughout the rest trial, nor did it change in the preexercise phase.
However, in contrast to the increases in glutamate, glutamine,
aspartate, alanine, and taurine during exercise, the rise in plasma
ammonia was attenuated during exercise after MSG ingestion
(P < 0.05). These ammonia data, together with the
results of glutamine and alanine, demonstrate a shift in nitrogen
distribution during exercise (Fig. 5).
Our results imply that an increase in glutamate availability leads to a
perturbed balance in the nitrogen carriers.
|
|
Lactate, glucose, insulin, and C peptide.
These data are summarized in Tables 3 and
4. During
the rest trials, there were no changes in lactate and glucose after ingestion of MSG. Insulin was modestly but significantly elevated from
30 to 60 min after MSG ingestion, coinciding with the peak increase of
plasma glutamate. C peptide followed a similar trend.
|
|
Glycerol and free fatty acids. Glycerol and free fatty acid data are also summarized in Tables 3 and 4. During the rest trials, there were no changes in glycerol. Glycerol levels were elevated during the MSG exercise trial, but significance was only reached at 10 min of exercise. Free fatty acid concentrations were not different in any of the four trials.
| |
DISCUSSION |
|---|
|
|
|---|
Enhanced glutamate availability was achieved via MSG ingestion to
investigate glutamate's effects on resting and exercise metabolism.
Previous studies have used MSG ingestion to examine cardiac and
pulmonary physiology during exercise; this is the only study, to our
knowledge, that has examined the metabolic implications of increased
glutamate availability during exercise. Providing glutamate in excess
resulted in a further elevation of plasma glutamate as well as
aspartate during exercise compared with rest. This increase in
circulating glutamate availability, as well as the resulting elevated
insulin levels, potentially led to increased intramuscular glutamate
levels, which ultimately may have induced a rise in plasma alanine
during exercise. MSG ingestion also resulted in specific exercise
responses of increased taurine levels and
O2. Although the increase in
O2 was small, it may imply elevated TCA
cycle flux during exercise after glutamate ingestion. Contrary to our
expectations, the shift in nitrogen distribution that occurred after
glutamate provision entailed a larger increase in plasma alanine, a
small increase in glutamine, and a decrease in ammonia over the entire
exercise period (Fig. 5).
MSG ingestion resulted in an ~18-fold increase in plasma glutamate during rest, which is similar to results of previous studies that administered MSG to humans (2, 15, 26-28). Surprisingly, there was a greater increase in plasma glutamate during exercise than at rest (mean peak increase was 601 ± 65 µM during exercise vs. 470 ± 52 µM during rest trials). The pronounced and rapid increase occurred with the onset of exercise and could be due to increased absorption at the gut or decreased clearance at the liver. However, with 40 min between the time that MSG is ingested and the time that exercise commences, absorption of glutamate at the gut should be completed. In addition, as exercise commences, blood flow is shifted away from the splanchnic region and shifted toward the exercising muscle; thus it is unlikely that there is an increased absorption of glutamate at the gut and more likely that there is a decreased clearance of glutamate, possibly by the liver.
We assume that glutamate is taken up by skeletal muscle, because the increased availability of plasma glutamate has been shown to increase glutamate arteriovenous differences during exercise (31) and increase intramuscular glutamate at rest (15). After a glutamate administration, Thomassen et al. (31) demonstrated an increase in glutamate arteriovenous difference across the leg. Graham and colleagues (15) observed intramuscular glutamate levels rise ~40% at rest within 40-60 min of MSG ingestion. Because the subjects in the present study rested for 40 min before exercise, it is very likely that intramuscular glutamate levels were elevated before the onset of exercise. It is also known that there is a greater uptake of glutamate by skeletal muscle during exercise (10, 17). Combined with a large glutamate concentration gradient from the circulation to muscle and the increase in insulin, there may be a further rise in intramuscular glutamate in the active muscle.
Although glutamate plays an integral role in numerous metabolic reactions, relatively few plasma amino acid concentrations (i.e., aspartate, taurine, alanine, and glutamine) were affected by glutamate ingestion. The most interesting effects were seen in plasma alanine, which did not change during rest trials and preexercise but notably increased during exercise. It is well established that plasma alanine increases during exercise (10, 17, 20). In the present study, we observed a rise in alanine during exercise; however, MSG enhanced this response. The rise in plasma alanine during exercise is likely attributed to the elevated production of alanine from the active muscle. If exercise time were extended, one may expect alanine to continue to rise if glutamate uptake continually increased intramuscular glutamate in the exercising muscle. Alanine, along with 2-oxoglutarate (a TCA cycle intermediate), is formed by the transamination of glutamate and pyruvate via alanine aminotransferase (AAT). Because AAT transamination is a near-equilibrium reaction, elevated levels of intramuscular glutamate from MSG administration, as well as elevated levels of pyruvate from an exercise-induced increase in glycolysis, could produce more 2-oxoglutarate and alanine in the muscle, whereby alanine would be released into circulation.
It has been proposed that 2-oxoglutarate is critical to oxidative
metabolism (10, 11, 32). At the onset of exercise, there
is an expansion of the TCA cycle intermediate pool (anaplerosis), but
2-oxoglutarate is the only TCA cycle intermediate to decrease after 1 min of exercise (10-13). One could speculate that an
increase in 2-oxoglutarate could result after MSG ingestion, which
could potentially modify TCA cycle flux. This may be supported by the ~2.5 ml · kg
1 · min
1
increase in
O2 that was observed during
exercise after MSG administration. Although 2.5 ml · kg
1 · min
1 appears to
be a small increase in
O2, it is
important to reiterate that this is a whole body measurement and can be
translated to ~170 ml/min of
O2.
Because
O2 did not change during rest
with MSG ingestion and with the large increase in blood flow to the exercising muscle at this high-intensity exercise, it would be assumed
that the majority of this increase in
O2
occurred in the exercising legs. Therefore, this elevated
O2 may be greater per kilogram of active
muscle and have more direct implications on the TCA cycle flux of the
exercising muscle. It is also important to note that the fitness level
of our subjects was high, which would also increase the
O2 of the exercising muscles, and thus may affect TCA cycle anaplerosis. However, one would also predict lower
lactate production, which, in contrast, tends to be elevated with MSG.
These data warrant future study using MSG ingestion as a tool to
investigate glutamate's role on TCA cycle anaplerosis.
Glutamine and ammonia also demonstrated interesting changes. Plasma ammonia and glutamine did not change during the rest trials after MSG ingestion. However, ammonia was attenuated with glutamate ingestion during exercise, similar to the results of Systrom et al. (29), whereas glutamine increased gradually. Previous work has shown that alanine, glutamine, and ammonia are released in equal amounts during exercise (20). Thus we hypothesized that the greater availability of glutamate from MSG administration would elevate these particular nitrogen carriers (alanine, glutamine, and ammonia) equally because they are involved in various metabolic reactions in which glutamate has an integral role. However, it appears that increased glutamate levels have led to a shift in the normal distribution of nitrogen, as MSG induced a pronounced increase in alanine and a modest increase in glutamine while plasma ammonia was attenuated during exercise. This shift in nitrogen balance is represented in Fig. 5, where percent change in area under the curve between Plb and MSG trials has been calculated for alanine, glutamine, and ammonia during the exercise trials. This shift in nitrogen distribution emphasizes the importance of glutamate in various transamination reactions. Glutamate and glutamine are known to have intimate interactions during exercise; whereas our results suggest that glutamate may have a more important role in alanine metabolism during exercise. These data depict a much greater shift toward the production of alanine vs. glutamine, which further supports glutamate's role in TCA cycle flux.
Aspartate substantially increased during the rest and exercise trials and was remarkably similar in time course and pattern with the increase in glutamate in both MSG trials. These increases, at rest, are similar to the increases in aspartate reported previously for resting subjects (15, 26-28). The elevated aspartate levels that result after MSG ingestion may be attributed to the interrelated metabolism of glutamate and aspartate. The increases seen in aspartate at rest and during preexercise potentially originate from transamination reactions in the gut as part of a "flooding effect." Glutamate is known as an important nutrient of splanchnic metabolism (3, 21) and can be sequestered, almost entirely, by the splanchnic bed when provided in small amounts (3, 21). Because there is such a large inflow of glutamate into the intestinal tract at rest, the intestinal cells most likely sequester and use what they need of the incoming glutamate, whereas the remainder may be released into circulation as glutamate or transaminated (via aspartate aminotransferase) into aspartate before being released. This may explain the similar time course of increase demonstrated by aspartate and glutamate. During exercise, the mechanisms responsible for the increases in aspartate are most likely different from those at rest. As the blood flow to the gut declines during exercise, the continued increase in plasma aspartate is likely due to a decreased clearance from the liver, as previously suggested with glutamate.
It has been debated whether the purine nucleotide cycle is important during exercise. With a greater availability of plasma aspartate and glutamate, one would expect an increase in intramuscular aspartate via increased uptake of aspartate from circulation or from transamination of elevated intramuscular glutamate, respectively. Graham et al. (15) have shown that MSG ingestion tends to increase intramuscular aspartate at rest. Therefore, there would be more substrate provided for the purine nucleotide cycle. This, in turn, would predict that ammonia would be elevated with increased purine nucleotide cycling. However, our data show that MSG results in an attenuated increase in ammonia during exercise, suggesting either that the purine nucleotide cycle is not active during exercise or that aspartate is directed toward other metabolic reactions (i.e., the production of oxaloacetate).
Surprisingly, taurine was another amino acid that was elevated after glutamate ingestion during the rest trials and to a much greater extent during exercise. The further increase during exercise may be due to a decrease in clearance, as suggested for glutamate and aspartate. Taurine is purported to have insulin-like actions on glucose utilization, although its actions are suggested to be independent of insulin (8, 22). It is possible that taurine, together with the rise in insulin, seen in the present study, may have prevented a rise in glucose during exercise after MSG ingestion. The physiological implications of glutamate ingestion on taurine metabolism are poorly understood. Although glutamate is central to numerous reactions, few changes in plasma amino acids resulted after glutamate ingestion. However, not only was taurine one of the few amino acids that was elevated with MSG ingestion, but it increased in a similar manner as plasma glutamate. Because glutamate and taurine appear to affect insulin independently (8, 22), the potential interrelationship between these two amino acids may further support a possible role toward insulin. Future investigations are certainly warranted to examine further glutamate's importance in taurine metabolism.
As seen in previous work, insulin was elevated after MSG ingestion (6, 15, 31). C peptide, which has not been measured in previous MSG studies, increased in a similar manner to insulin but was not significant. Several studies have demonstrated the existence of glutamate receptors in pancreatic cells (23, 33), and it has been suggested that glutamate may stimulate insulin secretion through these cells (19, 23). However, our data suggest that, whereas glutamate ingestion may have, in part, increased insulin secretion, glutamate ingestion may have also resulted in inhibiting the clearance of insulin.
In summary, MSG ingestion has several specific effects on amino acids such as glutamate, aspartate, glutamine, taurine, and alanine. Whereas glutamate and aspartate are elevated at rest after glutamate ingestion, these amino acids are elevated to a greater extent during exercise. MSG induces an enhanced increase in plasma alanine only during exercise, which may be a result of elevated intramuscular alanine production via the AAT transamination of elevated intramuscular glutamate from MSG and pyruvate from exercise-induced glycolysis. Glutamine also appears to be elevated during exercise after glutamate ingestion. Conversely, ammonia displays an attenuated increase with greater glutamate availability and exercise. These data suggest that increased glutamate availability during exercise alters its distribution, resulting in elevated alanine, modest increases in glutamine, and decreased ammonia.
| |
ACKNOWLEDGEMENTS |
|---|
The authors acknowledge the technical assistance of Premila Sathasivam and Danielle Battram.
| |
FOOTNOTES |
|---|
This work was supported by National Sciences and Engineering Research Council and by a student award from the Gatorade Sport Science Institute.
Address for reprint requests and other correspondence: M. Mourtzakis, Human Biology and Nutritional Science, Univ. of Guelph, Guelph, Ontario, Canada N1G 2W1 (E-mail: mmourtza{at}uoguelph.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
June 30, 2002;10.1152/japplphysiol.00111.2002
Received 13 February 2002; accepted in final form 25 June 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aoki, TT,
Brennan MF,
Müller WA,
Moore FD,
and
Cahill GF, Jr.
Effect of insulin on muscle glutamate uptake.
J Clin Invest
51:
2889-2894,
1972[ISI][Medline].
2.
Baker, GL,
Filer LJ, Jr,
and
Stegink LD.
Effect of carbohydrate on glutamate metabolism (Abstract).
Fed Proc
38:
610,
1979.
3.
Battezzati, A,
Brillon DJ,
and
Matthews DE.
Oxidation of glutamic acid by the splanchnic bed in humans.
Am J Physiol Endocrinol Metab
269:
E269-E276,
1995
4.
Beaunoyer, DE,
Jackson SG,
Gillespie JR,
and
Baker JP.
The effect of monosodium glutamate infusion on time to fatigue.
Equine Exercise Physiology
3:
209-214,
1991.
5.
Bergmeyer, H.
Methods of Enzymatic Analysis. New York: Academic, 1974, p. 1128-1135.
6.
Bertrand, G,
Puech R,
Loubatieres-Mariani MM,
and
Bockaert J.
Glutamate stimulates insulin secretion and improves glucose tolerance in rats.
Am J Physiol Endocrinol Metab
269:
E551-E556,
1995
7.
Blomstrand, E,
and
Saltin B.
Effect of muscle glycogen on glucose, lactate and amino acid metabolism during exercise and recovery in human subjects.
J Physiol
514:
293-302,
1999
8.
De Luca, G,
Calpona PR,
Caponetti A,
Romano G,
Di Benedetto A,
Cucinotta D,
and
Di Giorgio RM.
Taurine and osmoregulation: platelet taurine content, uptake, and release in Type 2 diabetic patients.
Metabolism
50:
60-64,
2001[ISI][Medline].
9.
Filer, LJ, Jr,
and
Stegink LD.
A report of the proceedings of an MSG workshop held August 1991.
Crit Rev Food Sci Nutr
34:
159-174,
1994[ISI][Medline].
10.
Gibala, MJ,
MacLean DA,
Graham TE,
and
Saltin B.
Anaplerotic processes in human skeletal muscle during brief dynamic exercise.
J Physiol
502:
703-713,
1997[ISI][Medline].
11.
Gibala, MJ,
MacLean DA,
Graham TE,
and
Saltin B.
Tricarboxylic acid cycle intermediate pool size and estimated cycle flux in human muscle during exercise.
Am J Physiol Endocrinol Metab
275:
E235-E242,
1998
12.
Gibala, MJ,
and
Saltin B.
PDH activation by dichloroacetate reduces TCA cycle intermediates at rest but not during exercise in humans.
Am J Physiol Endocrinol Metab
277:
E33-E38,
1999
13.
Gibala, MJ,
Tarnopolsky MA,
and
Graham TE.
Tricarboxylic acid cycle intermediates in human muscle at rest and during prolonged cycling.
Am J Physiol Endocrinol Metab
272:
E239-E244,
1997
14.
Graham, TE,
and
MacLean DA.
Ammonia and amino acid metabolism in skeletal muscle: human, rodent and canine models.
Med Sci Sports Exerc
30:
34-46,
1998[ISI][Medline].
15.
Graham, TE,
Sgro V,
Friars D,
and
Gibala MJ.
Glutamate ingestion: the plasma and muscle free amino acid pools of resting humans.
Am J Physiol Endocrinol Metab
278:
E83-E89,
2000
16.
Graham, TE,
Turcotte LP,
Kiens B,
and
Richter EA.
Training and muscle ammonia and amino acid metabolism in humans during prolonged exercise.
J Appl Physiol
78:
725-735,
1995
17.
Graham, TE,
Turcotte LP,
Kiens B,
and
Richter EA.
Effect of endurance training on ammonia and amino acid metabolism in humans.
Med Sci Sports Exerc
29:
646-653,
1997[ISI][Medline].
18.
Henrikson, RL,
and
Meredith SC.
Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate.
Anal Biochem
136:
65-74,
1984[ISI][Medline].
19.
Inagaki, N,
Kuromi H,
Gonoi T,
Okamoto Y,
Ishida H,
Seino Y,
Kaneko T,
Iwanaga T,
and
Seino S.
Expression and role of ionotropic glutamate receptors in pancreatic islet cells.
FASEB J
9:
686-691,
1995[Abstract].
20.
MacLean, DA,
Graham TE,
and
Saltin B.
Stimulation of muscle ammonia production during exercise following branched-chain amino acid supplementation in humans.
J Physiol
493:
909-922,
1996[ISI].
21.
Matthews, DE,
Marano MA,
and
Campbell RG.
Splanchnic bed utilization of glutamine and glutamic acid in humans.
Am J Physiol Endocrinol Metab
264:
E848-E854,
1993
22.
Maturo, J,
and
Kulakowski EC.
Taurine binding to the purified insulin receptor.
Biochem Pharmacol
37:
3755-3760,
1988[ISI][Medline].
23.
Molnár, E,
Váradi A,
McIlhinney RAJ,
and
Ashcroft SJH
Identification of functional ionotropic glutamate receptor proteins in pancreatic
-cells and in islets of Langerhans.
FEBS Lett
371:
253-257,
1995[ISI][Medline].
24.
Rennie, MJ.
Influence of exercise on protein and amino acid metabolism.
In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 12, chapt. 22, p. 995-1035.
25.
Stegink, LD,
Filer LJ, Jr,
and
Baker GL.
Effect of aspartame plus monosodium L-glutamate ingestion on plasma and erythrocyte amino acid levels in normal adult subjects fed a high-protein meal.
Am J Clin Nutr
36:
1145-1152,
1982
26.
Stegink, LD,
Filer LJ, Jr,
and
Baker GL.
Effect of carbohydrate on plasma and erythrocyte glutamate levels in humans ingesting large doses of monosodium L-glutamate in water.
Am J Clin Nutr
37:
961-968,
1983
27.
Stegink, LD,
Filer LJ, Jr,
Baker GL,
Mueller SM,
and
Wu-Rideout MYC
Factors affecting plasma glutamate levels in normal adult subjects.
In: Glutamic Acid: Advances in Biochemistry and Physiology, edited by Filer LJ, Jr,
and Stegink LD.. New York: Raven, 1979, p. 333-351.
28.
Stegink, LD,
Reynolds WA,
Filer LJ, Jr,
Baker GL,
Daabees TT,
and
Pitkin RM.
Comparative metabolism of glutamate in the mouse, monkey, and man.
In: Glutamic Acid: Advances in Biochemistry and Physiology, edited by Filer LJ, Jr,
and Stegink LD.. New York: Raven, 1979, p. 85-101.
29.
Systrom, DM,
Fragoso C,
Kanarek DJ,
and
Kazemi H.
Ammonium ion and the anaerobic threshold in man.
Chest
99:
1197-1202,
1991
30.
Thomassen, A,
Botker HE,
Nielsen TT,
Thygesen K,
and
Henningsen P.
Effects of glutamate on exercise tolerance and circulating substrate levels in stable angina pectoris.
Am J Cardiol
65:
173-178,
1990[ISI][Medline].
31.
Thomassen, A,
Nielsen TT,
Bagger JP,
and
Henningsen P.
Effects of intravenous glutamate on substrate availability and utilization across the human heart and leg.
Metabolism
40:
378-384,
1991[ISI][Medline].
32.
Wagenmakers, AJM
Muscle amino acid metabolism at rest and during exercise: role in human physiology and metabolism.
Exerc Sport Sci Rev
26:
287-314,
1998[ISI][Medline].
33.
Weaver, CD,
Gundersen V,
and
Verdoorn TA.
A high-affinity glutamate/aspartate transport system in pancreatic islets of Langerhans modulates glucose-stimulated insulin secretion.
J Biol Chem
273:
1647-1653,
1998
This article has been cited by other articles:
![]() |
A Bassini-Cameron, A Monteiro, A Gomes, J P S Werneck-de-Castro, and L Cameron Glutamine protects against increases in blood ammonia in football players in an exercise intensity-dependent way Br. J. Sports Med., April 1, 2008; 42(4): 260 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Rutten, M. P. Engelen, E. F. Wouters, A. M. Schols, and N. E. Deutz Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease Am. J. Clinical Nutrition, January 1, 2006; 83(1): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |